Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$821M |
| 2 |
AGN
Allergan plc
AGN
|
+$444M |
| 3 |
Apple
AAPL
|
+$304M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$301M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$839M |
| 2 |
Las Vegas Sands
LVS
|
+$405M |
| 3 |
Qualcomm
QCOM
|
+$402M |
| 4 |
Warner Bros
WBD
|
+$400M |
| 5 |
Perrigo
PRGO
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.61% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Communication Services | 12.98% |
| 4 | Technology | 11.5% |
| 5 | Energy | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Brunswick
BC
$5.33B
| $5.23M | ﹤0.01% |
124,044
+13,008
| +12% | +$551K |
|
502
Webster Financial
WBS
$12.5B
| $5.12M | ﹤0.01% |
175,613
+7,428
| +4% | +$221K |
|
|
TRNX
503
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $4.91M | ﹤0.01% |
205,246
+306
| +0.1% | +$6.84K |
|
|
SUNE
504
DELISTED
SUNEDISON, INC COM
SUNE
| $4.8M | ﹤0.01% |
253,999
-1,152
| -0.5% | -$24.7K |
|
|
AERI
505
DELISTED
Aerie Pharmaceuticals
AERI
| $4.79M | ﹤0.01% |
231,725
+338
| +0.1% | +$6.66K |
|
|
ETP
506
DELISTED
Energy Transfer Partners L.p.
ETP
| $4.65M | ﹤0.01% |
72,639
+51,141
| +238% | +$2.96M |
|
507
Piper Sandler
PIPR
$5.24B
| $4.44M | ﹤0.01% |
339,704
+23,552
| +7% | +$314K |
|
508
National Grid
NGG
$81.3B
| $4.41M | ﹤0.01% |
63,554
-9,120
| -13% | -$648K |
|
509
TG Therapeutics
TGTX
$8.4B
| $4.37M | ﹤0.01% |
409,409
+612
| +0.1% | +$5.67K |
|
|
YOKU
510
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $4.26M | ﹤0.01% |
237,752
-28,003
| -11% | -$563K |
|
|
WPZ
511
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
| $4.25M | ﹤0.01% |
85,116
+52,278
| +159% | +$2.6M |
|
512
Valero Energy
VLO
$88.7B
| $4.04M | ﹤0.01% |
+87,310
| New | +$4.4M |
|
513
Alaunos Therapeutics
TCRT
$4.64M
| $4.01M | ﹤0.01% |
10,120
+15
| +0.1% | +$7.23K |
|
514
Akebia Therapeutics
AKBA
$341M
| $3.97M | ﹤0.01% |
179,232
+257
| +0.1% | +$5.9K |
|
515
Verastem
VSTM
$547M
| $3.82M | ﹤0.01% |
37,397
| – | – |
|
|
ZSPH
516
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $3.82M | ﹤0.01% |
+97,292
| New | +$3.22M |
|
517
Tyson Foods
TSN
$21.5B
| $3.76M | ﹤0.01% |
+95,562
| New | +$3.66M |
|
518
Johnson & Johnson
JNJ
$643B
| $3.75M | ﹤0.01% |
35,206
-884
| -2% | -$91.7K |
|
519
Archer Daniels Midland
ADM
$40.1B
| $3.71M | ﹤0.01% |
72,639
-6,684
| -8% | -$328K |
|
520
Walmart Inc
WMT
$900B
| $3.69M | ﹤0.01% |
144,552
+49,539
| +52% | +$1.25M |
|
521
IBM
IBM
$214B
| $3.67M | ﹤0.01% |
+20,199
| New | +$3.68M |
|
522
Blackrock
BLK
$170B
| $3.66M | ﹤0.01% |
+11,144
| New | +$3.59M |
|
523
Chevron
CVX
$374B
| $3.58M | ﹤0.01% |
30,041
-679
| -2% | -$86.6K |
|
|
MRSH
524
Marsh
MRSH
$91.7B
| $3.57M | ﹤0.01% |
68,207
-2,705
| -4% | -$141K |
|
525
Cencora
COR
$62.2B
| $3.57M | ﹤0.01% |
+46,168
| New | +$3.51M |
|
Similar funds
Jennison Associates's Q3 2014 Portfolio in Review
As of Q3 2014, Jennison Associates held 788 positions worth $108B, down 0.96% from $109B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q3 2014 filing shows 82 new, 334 increased, 281 reduced and 71 closed positions. Its largest new stake was Alibaba: 9,140,584 shares worth $812M. The largest sale was RTX Corp, an estimated $839M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2014 buy was Alibaba: 9,140,584 shares worth $812M.
- Jennison Associates added most to Allergan plc in Q3 2014, an estimated $444M increase.
- Jennison Associates's biggest Q3 2014 reduction was Las Vegas Sands, cutting an estimated $405M.
- Jennison Associates fully exited RTX Corp in Q3 2014, selling an estimated $839M.
- Jennison Associates's ten largest holdings make up 20% of its $108B portfolio in Q3 2014.
- Jennison Associates opened 82 new positions and closed 71 in Q3 2014.
- Jennison Associates's portfolio value fell 0.96% quarter-over-quarter to $108B.
Based on Jennison Associates's 13F filing for Q3 2014, filed 5 Nov 2014.